HDAC5 and urothelial carcinoma: While these reports seemingly contradict our findings of the association of HDAC5 upregulation with sensitivity to kinase inhibitors, HDAC5 overexpression had dual effects in urothelial carcinoma cell lines, decreasing cell proliferation in multiple cell lines but increasing the epithelial-to-mesenchymal transition in one cell line [88].